Reh In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1122-YF4932
Target Cell Organism: Human
Target Cell Name: Reh
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide Reh-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Reh
Target Cell Organism
Human
Target Cell Background
Reh is a human cell line exhibiting lymphoblastic morphology that was isolated from tissue from an acute lymphocytic leukemia (ALL) patient. Use these cells in your immune system disorder and cancer research.
Related Diseases
Acute Lymphocytic Leukemia; ALL
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
Reh-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry